Given the fact that platelets express GARP on their surfaces and connecting this to previous works describing GARP as a key molecule in inducing peripheral tolerance, several groups have shown a possible contribution of platelets to adaptive immunity, leading to a poor prognosis of cancer patients with cancer associated thrombocytosis. This evidence concerns the gene LRRC32 and Thrombocytosis.